Cyclophosphamide/Epirubicin/Pembrolizumab Regimen

Preferred Label : Cyclophosphamide/Epirubicin/Pembrolizumab Regimen;

NCIt synonyms : EC Plus Pembrolizumab Regimen; EC Followed by Pembrolizumab Regimen; Cyclophosphamide-Epirubicin-Pembrolizumab; Cyclophosphamide/Epirubicin/Pembrolizumab; Cyclophosphamide-Epirubicin-Pembrolizumab Regimen; Ellence/Cytoxan Followed by Keytruda Regimen; EC/Pembrolizumab Regimen; Epirubicin/Cyclophosphamide Followed by Pembrolizumab Regimen; EC-Pembrolizumab Regimen;

NCIt definition : A regimen consisting of cyclophosphamide and epirubicin followed by pembrolizumab, used as a neoadjuvant or adjuvant treatment for HER-2 (EGFR2; ErbB2)-negative and hormone receptor-negative breast cancer.;

NCI Metathesaurus CUI : CL1664636;

Details

Origin ID

C181786;

UMLS CUI

C5557261;

Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Cyclophosphamide [NCIt concept]
- Epirubicin Hydrochloride [NCIt concept]
- Pembrolizumab [NCIt concept]
concept_is_in_subset
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients